ABC-SEPSIS trial for albumin in septic shock
Neither of two large randomized trials in the 2000s showed a benefit from albumin solutions as a resuscitation fluid for patients with septic shock.
Significant uncertainty remained, though, as we discussed further here:
Albumin as resuscitation fluid for septic shock: Review
Albumin is a protein produced by the liver whose molecular weight and negative charge attract sodium cations, and with them water molecules. In this way albumin produces most of the vascular system’s oncotic pressure—the force tending to retain fluid in blood vessels without its leaking into the extravascular space. This increases mean arterial pressure.
Another randomized trial was therefore performed, dubbed ABC-SEPSIS.
ABC-SEPSIS Trial
The ABC-SEPSIS trial (Gray et al Crit Care Med 2024…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.